Abstract
HIV testing/counseling is a critical point during which non-clinical staff could intervene, discuss and/or refer clients for pre-exposure prophylaxis (PrEP). This analysis investigated the contextual factors affecting PrEP implementation within HIV testing sites. Two generalized linear mixed models were conducted to estimate PrEP implementation as a function of constructs from the Consolidated Framework for Implementation Research (CFIR). Qualitative interviews were analyzed thematically. Data integration occurred via joint analysis and triangulation. Constructs from the CFIR domain Characteristics of Individuals did not predict PrEP implementation when controlling for demographic characteristics; qualitative data signaled divergent findings in PrEP knowledge. Within the CFIR domains Inner and Outer Settings, relevant priority and available resources predicted PrEP implementation; qualitative data confirmed the importance of available resources and provided insight into the impact of cosmopolitanism and leadership. Addressing the contextual factors that affect PrEP implementation may help HIV testing staff to better implement PrEP programs.
Similar content being viewed by others
References
Spinner CD, Boesecke C, Zink A, Jessen H, Stellbrink HJ, Rockstroh JK, et al. HIV pre-exposure prophylaxis (PrEP): a review of current knowledge of oral systemic HIV PrEP in humans. Infection. 2016;44(2):151–8.
Anderson PL, Glidden DV, Liu A, Buchbinder S, Lama JR, Guanira JV, et al. Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci Transl Med. 2012;4(151):151ra25.
CDC. PrEP 2016. http://www.cdc.gov/hiv/workplace/education/prep.html. Accessed 5 Oct 2016.
World Health Organization. Policy brief: pre-exposure prophylaxis (PrEP): WHO expands recommendation on oral pre-exposure prophylaxis of HIV infection (PrEP). Geneva, Switzerland: World Health Organization; 2015. p. 2. Report No. WHO/HIV/2015.48.
World Health Organization. Guidance on oral pre-exposure prophylaxis (PrEP) for serodiscordant couples, men and transgender women who have sex with men at high risk of HIV: recommendations for use in the context of demonstration projects. Geneva, Switzerland: World Health Organization; 2012. p.19. ISBN: 978 92 4 150388 4.
World Health Organization. Guidance on couples HIV testing and counselling including antiretroviral therapy for treatment and prevention in serodiscordant couples: recommendations for a public health approach. Geneva, Switzerland: World Health Organization; 2012. p. 79. ISBN 978 92 4 150197 2.
CDC. Pre-Exposure Prophylaxis (PrEP) 2014. http://www.cdc.gov/hiv/prevention/research/prep/. Accessed 9 March 2015.
The White House Office of National AIDS Policy. National HIV/AIDS strategy for the United States: Updated to 2020. In: Policy OoNA, editor. Washington, D.C.2015.
U.S. Public Health Service. Preexposure prophylaxis for the prevention of HIV infection in the United States –2014 clinical providers’ Supplement 2014.
Services USDoHH. Ending the HIV epidemic 2019. https://www.hiv.gov/federal-response/ending-the-hiv-epidemic/hiv-in-america. Accessed 14 Jan 2020
Krakower DS, Mayer KH. The role of healthcare providers in the roll-out of PrEP. Curr Opin HIV AIDS. 2016;11(1):41.
Smith DK, Maier E, Betts J, Gray S, Kolodziejski B, Hoover KW. What community-based HIV prevention organizations say about their role in biomedical HIV prevention. AIDS Educ Prev. 2016;28(5):426–39.
Krakower DS, Jain S, Mayer KH. Antiretrovirals for primary HIV prevention: the current status of pre- and post-exposure prophylaxis. Curr HIV/AIDS Rep. 2015;12(1):127–38.
Krakower DS, Mayer KH. The role of healthcare providers in the roll out of preexposure prophylaxis. Curr Opin HIV AIDS. 2016;11(1):41–8.
Krakower D, Mayer KH. Engaging healthcare providers to implement HIV pre-exposure prophylaxis. Curr Opin HIV AIDS. 2012;7(6):593–9.
Mayer KH, Chan PA, Patel RR, Flash CA, Krakower DS. Evolving models and ongoing challenges for HIV preexposure prophylaxis Implementation in the United States. J Acquir Immune Defic Syndr. 2018;77(2):119–27.
Smith DK, Dearing JW, Sanchez T, Goldschmidt RH. Introducing wicked issues for HIV pre-exposure prophylaxis implementation in the U.S. Am J Prev Med. 2013;44(1 Suppl 2):S59-62.
Underhill K, Morrow KM, Colleran CM, Holcomb R, Operario D, Calabrese SK, et al. Access to healthcare, HIV/STI testing, and preferred pre-exposure prophylaxis providers among men who have sex with men and men who engage in street-based sex work in the US. PLoS ONE. 2014;9(11):e112425.
Underhill K, Operario D, Mimiaga MJ, Skeer MR, Mayer KH. Implementation science of pre-exposure prophylaxis: preparing for public use. Curr HIV/AIDS Rep. 2010;7(4):210–9.
Underhill K, Operario D, Skeer M, Mimiaga M, Mayer K. Packaging PrEP to prevent HIV: an integrated framework to plan for pre-exposure prophylaxis implementation in clinical practice. J Acquir Immune Defic Syndr. 2010;55(1):8–13.
FDOH. DH1628 Laboratory request form 2012.
Parsons JT, John SA, Whitfield THF, Cienfuegos-Szalay J, Grov C. HIV/STI counseling and testing services received by gay and bisexual men using pre-exposure prophylaxis (PrEP) at their last PrEP care visit. Sex Transm Dis. 2018;45:798.
Hevey MA, Walsh JL, Petroll AE. PrEP Continuation, HIV and STI testing rates, and delivery of preventive care in a clinic-based cohort. AIDS Educ Prev. 2018;30(5):393–405.
Wilton J, Kain T, Fowler S, Hart TA, Grennan T, Maxwell J, et al. Use of an HIV-risk screening tool to identify optimal candidates for PrEP scale-up among men who have sex with men in Toronto, Canada: disconnect between objective and subjective HIV risk. J Int AIDS Soc. 2016;19(1):20777.
Kwan TH, Lee SS. Predictors of HIV testing and their influence on PrEP acceptance in men who have sex with men: a cross-sectional study. AIDS Behav. 2018;22(4):1150–7.
Flash CA, Adegboyega OO, Yu X, Avalos C, Johnson S, Mayer KH, et al. Correlates of linkage to HIV preexposure prophylaxis among HIV-testing clients. JAIDS J Acquir Immune Defic Syndr. 2018;77(4):365–72.
Hammack PL, Meyer IH, Krueger EA, Lightfoot M, Frost DM. HIV testing and pre-exposure prophylaxis (PrEP) use, familiarity, and attitudes among gay and bisexual men in the United States: a national probability sample of three birth cohorts. PLoS ONE. 2018;13(9):e0202806.
Turner D, Lockhart E, Wang W, Shore R, Daley EM, Marhefka SL. PrEP implementation behaviors of community-based HIV testing staff: a mixed methods approach using latent class analysis. J Acquir Immune Defic Syndr. 2020;83:467.
Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4:50.
Creswell JW. Research design: qualitative, quantitative, and mixed methods approaches. Thousand Oaks: Sage publications; 2013.
Qualtrics. Provo, Utah, USA2017.
Dillman DA. Mail and internet surveys: the tailored design method—2007 update with new internet, visual, and mixed-mode guide. New York: Wiley; 2011.
Blumenthal J, Jain S, Krakower D, Sun X, Young J, Mayer K, et al. Knowledge is Power! increased provider knowledge scores regarding pre-exposure prophylaxis (PrEP) are associated with higher rates of PrEP prescription and future intent to prescribe PrEP. AIDS Behav. 2015;19(5):802–10.
Walsh JL, Petroll AE. Using the information-motivation-behavioral skills model to predict discussion and prescription of pre-exposure propohylaxis among primary care providers. American Public Health Association 144th Annual Meeting and Expo; November 2, 2016; Denver, CO2016.
Helfrich CD, Li Y-F, Sharp ND, Sales AE. Organizational readiness to change assessment (ORCA): development of an instrument based on the promoting action on research in health services (PARIHS) framework. Implement Sci. 2009;4(38):38.
Damschroder. CFIR Technical Assistance Website 2016. http://cfirguide.org/. Accessed 29 April 2015
Gustafson DH, Sainfort F, Eichler M, Adams L, Bisognano M, Steudel H. Developing and testing a model to predict outcomes of organizational change. Health Serv Res. 2003;38(2):751–76.
SPSS I. IBM SPSS statistics for Windows, version 20.0. New York: IBM Corp. 2011.
Heck RH, Thomas S, Tabata L. Multilevel modeling of categorical outcomes using IBM SPSS: Routledge; 2013.
Kuckartz U. MAXQDA: Qualitative data analysis. Berlin: VERBI software; 2007.
Guest G, MacQueen KM, Namey EE. Applied thematic analysis. Thousand Oaks: Sage; 2011.
Creswell JW, Klassen AC, Plano Clark VL, Smith KC. Best practices for mixed methods research in the health sciences. Bethesda, MD: National Institutes of Health; 2011. p. 10.
Fetters MD, Curry LA, Creswell JW. Achieving integration in mixed methods designs—principles and practices. Health Serv Res. 2013;48(6pt2):2134–56.
Tellalian D, Maznavi K, Bredeek UF, Hardy WD. Pre-exposure prophylaxis (PrEP) for HIV infection: results of a survey of HIV healthcare providers evaluating their knowledge, attitudes, and prescribing practices. AIDS Patient Care STDS. 2013;27(10):553–9.
Calabrese SK, Magnus M, Mayer KH, Krakower DS, Eldahan AI, Gaston Hawkins LA, et al. Putting PrEP into practice: lessons learned from early-adopting US providers’ firsthand experiences providing HIV pre-exposure prophylaxis and associated care. PLoS ONE. 2016;11(6):e0157324.
White JM, Mimiaga MJ, Krakower DS, Mayer KH. Evolution of Massachusetts physician attitudes, knowledge, and experience regarding the use of antiretrovirals for HIV prevention. AIDS Patient Care STDS. 2012;26(7):395–405.
FDOH. The basics of HIV/AIDS counseling, testing, and linkage course HIV/AIDS 500 & HIV/AIDS 501 2018. http://www.floridahealth.gov/diseases-and-conditions/aids/prevention/_documents/Counseling_testing/500-501-Participant-Manual-2018.pdf. Accessed 20 Nov 2018
FDOH. Epidemiology of HIV infection trends in florida diagnosed through 2014: Florida Department of Health; 2016. http://www.floridahealth.gov/%5C/diseases-and-conditions/aids/surveillance/_documents/hiv-aids-slide-sets/2014/state_trends_2014b.pdf. Accessed 20 Sept 2016.
Acknowledgements
We would like to acknowledge the participants for their service to our communities and for taking part in this research. This study was funded, in part, via the USF College of Public Health Research Award and the USF Graduate School Dissertation Completion Fellowship Award. Further data analyses and preparation reported in this paper were completed by the primary author during a postdoctoral fellowship supported by the National Institute of Mental Health under award number T32MH020031 (PI: Kershaw). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Turner, D., Lockhart, E., Wang, W. et al. Examining the Factors Affecting PrEP Implementation Within Community-Based HIV Testing Sites in Florida: A Mixed Methods Study Applying the Consolidated Framework for Implementation Research. AIDS Behav 25, 2240–2251 (2021). https://doi.org/10.1007/s10461-020-03152-1
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10461-020-03152-1


